Search

everythinglearnresearchcommunity

for

Search:↓

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

A new one-step test can quickly identify skin cancer during surgery.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Bempikibart may help regrow hair in people with alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.